scholarly journals Getting the Price Right? The Impact of Competitive Bidding in the Medicare Program

2021 ◽  
Author(s):  
Hui Ding ◽  
Mark Duggan ◽  
Amanda Starc
Keyword(s):  
Competitive Bidding ◽  
Medicare Program ◽  
The Impact

scholarly journals COST-BENEFIT ANALYSIS OF HEARING CARE SERVICES AMONG MEDICARE BENEFICIARIES WITH HEARING AIDS

2019 ◽  
Vol 3 (Supplement_1) ◽  
pp. S43-S44
Author(s):  
Amber Willink ◽  
Amber Willink ◽  
Nicholas S Reed ◽  
Frank R Lin
Keyword(s):  
Older Adults ◽  
Hearing Aids ◽  
Cost Benefit Analysis ◽  
Skilled Nursing Facility ◽  
Medicare Beneficiaries ◽  
Cross Sectional ◽  
Care Services ◽  
Medicare Program ◽  
The Impact ◽  
Medicare Spending

Abstract Hearing care services for older adults with hearing aids are underutilized and are not covered by the Medicare program. Little information exists to the value of hearing care services for older adults with hearing aids. Using the Medicare Current Beneficiary Survey 2013, we conducted a cross-sectional analysis of the impact of hearing care services use on Medicare spending among those with hearing aids. Older Medicare beneficiaries with hearing aids that received hearing care services in the previous 12 months were propensity score matched to those who did not receive services. Average annual Medicare spending was $8196 (CI:$6670-$9723) among Medicare beneficiaries who used hearing care services and $10,709 (CI:$8878-12541) among matched controls. Spending differences were driven by higher skilled nursing facility and home health spending among matched controls. Increasing access to hearing care services among Medicare beneficiaries with hearing aids may provide value to the health care system and Medicare program.

The impact of comorbidity on survival among men with localized prostate cancer.

2011 ◽  
Vol 29 (7_suppl) ◽  
pp. 8-8 ◽  
Author(s):  
G. L. Lu-Yao ◽  
D. Moore ◽  
W. Shih ◽  
Y. Lin ◽  
H. Li ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Gleason Score ◽  
Tumor Grade ◽  
Tumor Stage ◽  
Localized Prostate Cancer ◽  
Medicare Program ◽  
Co Morbidity ◽  
Underlying Causes ◽  
Morbidity Index ◽  
The Impact

8 Background: To provide patients and clinicians more accurate estimates of co-morbidity specific survival stratified by patient age, tumor stage and tumor grade. Methods: We conducted a ten year competing risk analysis of 19,639 men age 66 years and older identified by the Surveillance, Epidemiology and End Results (SEER) program linked to Medicare program files. All men were diagnosed with localized prostate cancer and received no surgery or radiation within 180 days of diagnosis. The analysis was stratified by tumor grade and stage and by age and co-morbidity at diagnosis classified using the Charlson co-morbidity index. Underlying causes of death were obtained from SEER. Results: During the first ten years following diagnosis men with moderately and poorly differentiated prostate cancer were more likely to die from causes other than their disease. For men age 66-74 years with stage T1c Gleason score 5-7 disease at diagnosis, ten year overall mortality rates and prostate cancer specific rates were 28.8%, 50.5%, 83.1% and 4.8%, 2.0%, 5.3% respectively for men with Charlson scores 0, 1 and > 2. For men age 66-74 years with T1c Gleason score 8-10 disease at diagnosis, the corresponding rates were 55.0%, 52.0%, 64.3% and 25.7%, 20.2%, 13.7% respectively for men with Charlson scores 0, 1, > 2. Death from competing medical hazards was roughly comparable for men with stage T2 disease and higher for all men over age 75. Conclusions: Patients and clinicians should consider using co-morbidity specific data to estimate the threat posed by localized prostate cancer. No significant financial relationships to disclose.

scholarly journals The Impact of Hospital-Acquired Conditions on Medicare Program Payments

2014 ◽  
Vol 4 (4) ◽  
pp. E1-E23 ◽  
Author(s):  
Amy Kandilov ◽  
Nicole Coomer ◽  
Kathleen Dalton
Keyword(s):  
Medicare Program ◽  
Hospital Acquired Conditions ◽  
Hospital Acquired ◽  
The Impact

The Medicare Prescription Drug, Improvement and Modernization Act and the Impact on Care of People With Chronic Illness: Benefit Design and Implementation Issues

2004 ◽  
Vol 5 (2) ◽  
pp. 113-121
Author(s):  
Claudia Schlosberg
Keyword(s):  
Chronic Illness ◽  
Prescription Drug ◽  
Drug Benefit ◽  
Medicare Beneficiaries ◽  
Benefit Design ◽  
Prescription Drug Benefit ◽  
Department Of Health ◽  
Important Benefit ◽  
Medicare Program ◽  
The Impact

The Medicare Prescription Drug, Improvement and Modernization Act represents the most far-reaching and one of the most controversial reforms of the Medicare program since its enactment in 1965. The Act ushers in a new Medicare prescription drug benefit, revitalizes Medicare Advantage plans and promotes new approaches to care of Medicare beneficiaries with chronic illness. However, while the Act evidences a commitment to improving the care of beneficiaries with chronic illness, reform may prove elusive. The basic benefit design is daunting in its complexity and for certain beneficiaries, coverage may be less generous and less comprehensive than currently available coverage. To ensure appropriate transition and treatment for dual eligibles and others with chronic illness, both Congress and the Department of Health and Human Services must be prepared to address a number of important benefit design and operations issues and be willing to make mid-course corrections and adjustment as the process unfolds.

Sign in / Sign up

Export Citation Format

Share Document